Optum Rx will increase reimbursements to pharmacies for brand-name drugs and cut them for generics.  Optum Rx said the new ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), ...

Basically, a brand-name drug company settles a patent infringement lawsuit by paying cash or transferring something else of ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, is offering a new suite of ...

OptumRx is changing the way it pays pharmacies, reimbursing them more for branded drugs and less for generics, the company ...

The first time Dr. Fajgenbaum repurposed a drug, it was in an attempt to save his own life. At 25, while in medical school, ...

Eli Lilly has launched its diabetes and weight-loss drug, Mounjaro, in India, outpacing competitor Novo Nordisk. With ...

Amneal Pharmaceuticals, Inc. offers strong growth prospects with undervalued stock, rising revenues, reduced debt, and key ...

The direct to patients channel will also help pharmaceutical manufacturers to regain their share from generics. For example, according to a Reuters report, Arimidex reported sales of $880 million ...

UnitedHealth’s (NYSE:UNH) pharmacy benefit manager, Optum Rx, announced Thursday the launch of cost-based payment models to ...